Skip to content
Screener

EPS (Diluted) at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
-$3.49-1,486%
Opko Health logo
Opko HealthOPK
-$0.01+94.7%
Merck & Co. logo
Merck & Co.MRK
-$0.54-131%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$0.29+48.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$0.79-142%
APG
APGEAPGE
-$1.06-11.6%

Other financials

Income statement

See full
Revenue$41.0M-49.5%
Gross profit$23.4M-57.8%
Operating income$13.9M-69.6%
Net income$12.5M-64.9%

Balance sheet

See full
Cash & equivalents$117.6M-35.6%
Total debt$439.4K-58.8%
Total equity$165.3M-21.0%
Total assets$175.7M-25.3%

Cash flow

See full
Operating cash flow$15.2M-75.9%
CapEx--100%
Free cash flow$15.2M-75.9%

Valuation

See full
Market cap$214.11M-66.7%
Enterprise value$96.97M-79.0%
P/E5.6×+2.0×
P/S+0.4×

Profitability

See full
Gross margin54.4%-22.6pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio21.7×+11.6×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: SIGA Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:46 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001437749-26-026314
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income, net946,8981,592,3042,224,3783,277,288
Income before income taxes14,852,47647,272,17310,808,79446,701,758
Provision for income taxes(2,389,042)(11,789,070)(1,799,610)(11,626,878)
Net and comprehensive income$12,463,434$35,483,103$9,009,184$35,074,880
Basic income per share$0.17$0.50$0.13$0.49
Diluted income per share$0.17$0.49$0.13$0.49
Weighted average shares outstanding: basic71,752,53971,465,52171,701,53171,446,629
Weighted average shares outstanding: diluted71,883,79871,748,88871,998,57371,678,838

Item 1 - Condensed Consolidated Financial Statements

FAQ

What is SIGA Technologies's EPS (diluted)?
SIGA Technologies (SIGA) reported EPS (diluted) of $0.17 in Q2 2026.
How has SIGA Technologies's EPS (diluted) changed year-over-year?
SIGA Technologies's EPS (diluted) decreased by 65.3% year-over-year, from $0.49 to $0.17.
What is the long-term trend for SIGA Technologies's EPS (diluted)?
Over 3 years (2021 to 2024), SIGA Technologies's EPS (diluted) has grown at a -3.1% compound annual growth rate (CAGR), from $0.90 to $0.82.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about SIGA Technologies's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude